Site of opioid action in the human brain: Mu and kappa agonists' subjective and cerebral blood flow effects

American Journal of Psychiatry

Volumn 155, Issue 4, 1998, Pages 470-473

  Schlaepfer, Thomas E ^a   Strain, Eric C ^b   Greenberg, Benjamin D ^b   Preston, Kenzie L ^b   Lancaster, Eric ^b   Bigelow, George E ^b   Barta, Patrick E ^b   Pearlson, Godfrey D ^b  

^a PSI   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUTORPHANOL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HYDROMORPHONE; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; PLACEBO;

ANALGESIA; ARTICLE; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG EFFECT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEURORADIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031977485     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.4.470     Document Type: Article

References (25)

1. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE: The effects of morphine- and nalorphine-like drugs in the non- dependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976; 197:517-532
2. Martin WR: Pharmacology of opioids. Pharmacol Rev 1984; 35:283-323
3. Jaffe JH, Martin WR: Opioid analgesics and antagonists, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th ed. Edited by Gilman AG, Goodman LS, Rall TW, Murad F. New York, MacMillan, 1985, pp 491-531
4. Unterwald EM, Home-King J, Kreek MJ: Chronic cocaine alters brain mu opioid receptors. Brain Res 1992; 584:314-318
5. Spealman RD, Bergman J: Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 1992; 261:607-615
6. Kornetsky C, Porrino LJ: Brain mechanisms of drug-induced reinforcement. Res Publ Assoc Res Nerv Ment Dis 1992; 70:59-77
7. Preston KL, Bigelow GE, Bickel WK, Liebson IA: Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 1989; 250:184-196
8. Preston KL, Liebson IA, Bigelow GE: Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination. J Pharmacol Exp Ther 1992; 261:62-71
9. Oliveto AH, Bickel WK, Kamien JB, Hughes JR, Higgins ST: Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology (Berl) 1994; 114:417-123
10. Strain EC, Preston KL, Liebson IA, Bigelow GE: Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J Pharmacol Exp Ther 1993; 267:624-634
11. Schlaepfer TE, Pearlson GD: Pitfalls in SPECT studies of acute ethanol-induced changes in cerebral blood flow (letter). Am J Psychiatry 1995; 152:1695-1696
12. Friston KJ, Passingham RE, Nutt JG, Heather JD, Sawle GV, Frackowiak RS: Localisation in PET images: direct fitting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab 1989; 9:690-695
13. Friston KJ, Frith CD, Liddle PF, Frackowiak RS: Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991; 11:690-699
14. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS: The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990; 10:458-166
15. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical, 1988
16. Adler RJ: The Geometry of Random Fields. New York, John Wiley & Sons, 1981
17. Friston K, Holmes A, Worsley K, Poline J, Frith C, Frackowiak R: Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 1995; 2:189-210
18. Worsley KJ, Evans AC, Marrett S, Neelin P: A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992; 12:900-918
19. Vonvoigtlander P, Lahti R, Ludens J: U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 1983; 224:7-12
20. Jones AK, Friston KJ, Qi LY, Harris M, Cunningham VJ, Jones T, Feinman C, Frackowiak RS: Sites of action of morphine in the brain (letter). Lancet 1991; 338:825
21. Adler L, Firestone L, Winter P, Mintun M: Elucidation of central mechanisms of opioid analgesia by positron emission tomography (abstract). J Nucl Med 1994; 198P
22. van Dyck CH, Rosen MI, Thomas HM, McMahon TJ, Wallace EA, O'Connor PG, Sullivan M, Krystal JH, Hoffer PB, Woods SW, Kosten TR: SPECT regional cerebral blood-flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Res: Neuroimaging 1994; 55:181-191
23. Gabriel M, Orona E, Foster K, Lambert R: Mechanisms and generality of stimulus significance coding in a mammalian model system. Advances in Behavioral Biology 1982; 26:535-567
24. Maurer R, Cortes R, Probst A, Palacios JM: Multiple opiate receptor in human brain: an autoradiographic investigation. Life Sci 1983; 33(suppl 1):231-234
25. Pfeiffer A, Pasi A, Mehraein P, Herz A: Opiate receptor binding sites in human brain. Brain Res 1982; 248:87-96